taxifolin has been researched along with angiotensin ii in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chen, RC; Ma, XJ; Sun, GB; Sun, X; Sun, XB; Wang, M; Yang, LJ; Yang, ZH | 1 |
Guo, R; Li, Y; Tao, L; Xu, Y | 1 |
2 other study(ies) available for taxifolin and angiotensin ii
Article | Year |
---|---|
Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis.
Topics: Angiotensin II; Animals; Apoptosis; Caspases; Cell Line; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Enzyme-Linked Immunosorbent Assay; In Situ Nick-End Labeling; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oxidative Stress; Quercetin; Rats; Reactive Oxygen Species; Streptozocin | 2014 |
Taxifolin ameliorates abdominal aortic aneurysm by preventing inflammation and apoptosis and extracellular matrix degradation via inactivating TLR4/NF-κB axis.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apoptosis; Disease Models, Animal; Extracellular Matrix; Humans; Inflammation; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; NF-kappa B; Toll-Like Receptor 4 | 2023 |